Patent US3706106A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4238508A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for analgesia using 3-hydroxyacetanilide

Assignee: Research Foundation of the State University of New York
•
Filing: 1979-08-17
•
Granted: 1980-12-09
•
Expires: 1999-08-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for providing analgesia to warm blooded animals which comprises administering sufficient 3-hydroxyacetanilide of the formula: ##STR1##

Inventors

  • 👤 Edward B. Nelson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:08
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/16; A61K31/165

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 47 words
A method for providing analgesia which comprises administering to a warm blooded animal in need of analgesia, sufficient 3-hydroxyacetanilide in a quantity of from about 3 to about 400 milligrams per kilogram of body weight of the animal said 3-hydroxyacetanilide being of the formula: R1 ? ##STR3##
Claim 2
Independent Claim 47 words
A method for providing analgesia which comprises administering to a warm blooded animal in need of analgesia, sufficient 3-hydroxyacetanilide in a quantity of from about 3 to about 400 milligrams per kilogram of body weight of the animal said 3-hydroxyacetanilide being of the formula: R1 ? ##STR3##
Claim 3
Dependent Claim 13 words
The method of claim 1 wherein the warm blooded animal is a mammal.
Claim 4
Dependent Claim 22 words
The method of claim 2 wherein the sufficient 3-hydroxyacetanilide is from about 3 to about 12 milligrams per kilogram of body weight.
Claim 5
Dependent Claim 11 words
The method of claim 2 wherein the 3-hydroxyacetanilide is administered orally.
Claim 6
Dependent Claim 11 words
The method of claim 2 wherein the 3-hydroxyacetanilide is administered subcutaneously.
Claim 7
Dependent Claim 19 words
The method of claim 2 wherein the 3-hydroxyacetanilide is compounded with at least one inert pharmaceutical carrier or diluent.
Claim 8
Dependent Claim 14 words
The method of claim 2 wherein the 3-hydroxyacetanilide is orally administered in tablet form.
Claim 9
Dependent Claim 11 words
The method of claim 2 wherein the 3-hydroxyacetanilide is administered intraperitoneally.
Claim 10
Dependent Claim 20 words
The method of claim 4 wherein the dosage is about 3 to about 12 milligrams per kilogram of body weight.

References Cited (Backward Citations)

GB1006558A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-12-09 1984-06-09 1984-12-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-12-09 1988-06-09 1988-12-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-12-09 1992-06-09 1992-12-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag